Clinical Trial Update: Adjuvant Adebrelimab Plus Apatinib After Chemoradiation in Limited-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating adjuvant adebrelimab plus apatinib after chemoradiation in limited-stage small cell lung cancer; currently enrolling by invitati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Apatinib (apatinib)

Snippet

Sponsor: Second Affiliated Hospital of Nanchang University | Conditions: Limited-stage Small Cell Lung Cancer (LS-SCLC) | Phase 2 | Status: ENROLLING_BY_INVITATION